On a *non-GAAP basis, InMode reported net income of $24.5 million, or $0.38 per diluted share, in the third quarter of 2025, compared to $55.0 million, or $0.70 per diluted share, in the third quarter ...

Despite a highly profitable business model and a strong position in the medical aesthetics industry, INMD stock is down -33% over the last 12 months. Macroeconomic pressures, political risks in InMode ...

InMode (INMD) designs, develops, manufactures, and markets minimally invasive aesthetic medical products. In addition, it designs, develops, manufactures, and markets non-invasive medical aesthetic ...

Medical devices company InMode (NASDAQ:INMD) has fallen out of favor with investors in the past two years for various reasons, which we'll explain below. However, now that it's down 76% from highs, ...

InMode (NASDAQ:INMD) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-10. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

This article was published on Feb. 24, 2026, at 10:15 a.m. on the ChosunBiz MoneyMove site. Global aesthetic medical device corporation InMode, listed on the U.S. Nasdaq, has decided to suspend the ...

SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of InMode Ltd. (NASDAQ: INMD) common stock between June 4, 2021 and October 12, 2023, inclusive ...

YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...

On Wednesday, 11 March 2026, InMode Ltd (NASDAQ:INMD) presented its strategic vision at the Barclays 28th Annual Global Healthcare Conference. The company, navigating a challenging market environment, ...